The Effect of Preoperative Administration of Oral Tizanidine on the Postoperative Pain and Sleep Quality
Tizanidine
1 other identifier
interventional
68
1 country
1
Brief Summary
The majority of lower limb fractures treated with surgery often leading to significant morbidity and mortality. Despite improvements in perioperative care, about 20% suffer from severe postoperative complications. So, effective perioperative pain management is crucial in this demographic to ensure optimal recovery and reduce complications. (1) Controlling the postoperative pain often begins in recovery room by using opioids, especially morphine. However, systemic opioids may develop many complications such as nausea and vomiting, apnea, respiratory depression, and urinary retention. To reduce the complications and consumption of the opioids, other procedures are recommended. One of these procedures is preemptive analgesia(2). In addition to pain, disrupted sleep quality is a common challenge, with evidence suggesting a bidirectional relationship where poor sleep exacerbates pain, and pain further disrupts sleep (3). Addressing both pain and sleep disturbances in the perioperative period is therefore critical for enhancing recovery and improving overall patient outcomes
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
August 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
CompletedFirst Posted
Study publicly available on registry
September 2, 2026
CompletedSeptember 2, 2026
March 1, 2026
6 months
August 29, 2026
August 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Time to first request of rescue analgesia
24 hr
opioid consumption in 48 hrs postoperatively
48hr
Study Arms (2)
tizanidine group
EXPERIMENTALtizanidine
placebo group
PLACEBO COMPARATORplacebo
Interventions
Eligibility Criteria
You may qualify if:
- Adults aged ≥ 21 years
- Scheduled for lower limb orthopedic surgery
- Able to provide informed consent
You may not qualify if:
- History of hypersensitivity to tizanidine
- Pregnancy or breastfeeding
- Failure of spinal anesthesia or inadequate block.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
tanta University hospital
Tanta, Gharbia Governorate, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Marwa Ahmed Abogabal
Study Record Dates
First Submitted
August 29, 2026
First Posted
September 2, 2026
Study Start
March 1, 2026
Primary Completion
September 1, 2026
Study Completion
September 1, 2026
Last Updated
September 2, 2026
Record last verified: 2026-03